Cancer research
A recent systematic review and meta-analysis published in the journal Healthcare has found that AI-assisted colonoscopy significantly improves the detection rate of colorectal cancer compared to standard colonoscopy. The study, conducted by researchers from the University of Miami, analyzed 12 randomized controlled trials involving over 11,000 patients and found
Cancer research
Researchers at the Department of Medical Imaging in Guangzhou, China, have made a groundbreaking discovery in cancer therapy. By combining immunogenic cell death induction with STING pathway activation, they have developed a multifunctional nanoplatform that enhances cancer immunotherapy. This innovative approach has shown promise in promoting dendritic cell maturation and
Biomedical laboratories
Research from a team at the August Pi i Sunyer Biomedical Research Institute has identified a link between SMARCA4 pathogenic variants and ovarian cancer. The study, published in Gynecologic Oncology, analyzed individuals with a SMARCA4 germline pathogenic/likely pathogenic variant (gPV) to inform guidance on surveillance and prevention. The study
Cancer research
Researchers at Qingdao University have published a study on the application of chemotherapy using a combination of platinum and taxane agents in treating ovarian cancer. The study reveals that the abnormality of the nuclear pore complex (NPC) leads to nuclear envelope destruction and disrupts transmembrane transport, causing abnormal substance exchange.
Cancer research
Research has been conducted to study the impact of Wilms' tumor 1 gene (WT1) mutation on outcomes of allogeneic hematopoietic-cell transplantation for acute myeloid leukemia (AML). A study published in Bone Marrow Transplantation compared the outcomes of 703 patients with WT1 mutation (mWT1) to those with wild-type WT1 AML
Cancer research
Research conducted at the Third Affiliated Hospital of Sun Yat-Sen University in Guangzhou, People's Republic of China, has demonstrated the safety and efficacy of combining M1-c6v1 oncolytic virus with camrelizumab and apatinib in patients with advanced hepatocellular carcinoma (HCC). The study, which enrolled 13 patients, showed a 70%
Cancer research
Investigators at the Guangzhou Medical University in China have published a new study evaluating the efficacy and safety of two combination treatments for hepatocellular carcinoma (HCC). The researchers analyzed the outcomes of 459 HCC patients who underwent either transarterial chemoembolization (TACE) with hepatic arterial infusion chemotherapy (HAIC) combined with molecular
Cancer research
Recent research from Koc University Hospital in Istanbul, Turkiye, has shed light on the effectiveness of a modified port implantation technique in improving intraperitoneal chemotherapy (IPCT) outcomes for patients with stage III and IV ovarian cancers. The study found that patients who received 7 cycles or more of IPCT using
Cancer research
Researchers at Medical University - Pleven have made significant progress in understanding the development and progression of cervical cancer, a leading cause of death in women worldwide. The study, published in the Journal of Biomedical & Clinical Research, highlights the impact of cytokines, such as interleukin-6 (IL-6) and tumour necrosis
Cancer patients
A unique case of ovarian cancer complicated by chylothorax, a rare condition, has been documented by researchers. The patient, a 64-year-old woman, presented with advanced ovarian cancer that had extensive lymphatic metastasis and a right pleural effusion. After thoracentesis, the drainage fluid had a milky white appearance with triglyceride levels
Cancer research
A new report discusses the effectiveness of polatuzumab vedotin combined with rituximab and bendamustine in patients with relapsed or refractory diffuse large B-cell lymphoma. Research conducted at the Chiba Cancer Center Research Institute in Japan found that patients treated with this therapy showed improved overall survival rates and were more
Cancer research
Ovarian cancer, a highly lethal malignancy, is often diagnosed at late stages and develops chemoresistance, making treatment a significant challenge. Existing preclinical models have limitations in recapitulating the structural and functional complexity of the ovarian tumour microenvironment. However, a new study from Imperial College London suggests that tumour-on-chip (CoC) technology
